{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:27:48Z","timestamp":1790674068290,"version":"4.1.0"},"reference-count":93,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2017,6,11]],"date-time":"2017-06-11T00:00:00Z","timestamp":1497139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,6,11]],"date-time":"2017-06-11T00:00:00Z","timestamp":1497139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1111\/bjd.15065","type":"journal-article","created":{"date-parts":[[2016,9,17]],"date-time":"2016-09-17T15:49:00Z","timestamp":1474127340000},"page":"84-106","source":"Crossref","is-referenced-by-count":113,"title":["Skin absorption through atopic dermatitis skin: a systematic review"],"prefix":"10.1093","volume":"177","author":[{"given":"A.-S.","family":"Halling-Overgaard","sequence":"first","affiliation":[{"name":"Department of Dermatology and Allergy; Herlev and Gentofte Hospital; University of Copenhagen; DK-2900 Hellerup Denmark"},{"name":"National Allergy Research Centre; Herlev and Gentofte Hospital; University of Copenhagen; DK-2900 Hellerup Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kezic","sequence":"additional","affiliation":[{"name":"Coronel Institute of Occupational Health; Academic Medical Centre; Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Jakasa","sequence":"additional","affiliation":[{"name":"Laboratory for Analytical Chemistry; Department of Chemistry and Biochemistry; Faculty of Food Technology and Biotechnology; University of Zagreb; Zagreb Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.","family":"Engebretsen","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy; Herlev and Gentofte Hospital; University of Copenhagen; DK-2900 Hellerup Denmark"},{"name":"National Allergy Research Centre; Herlev and Gentofte Hospital; University of Copenhagen; DK-2900 Hellerup Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Maibach","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of California San Francisco; San Francisco CA U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Thyssen","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy; Herlev and Gentofte Hospital; University of Copenhagen; DK-2900 Hellerup Denmark"},{"name":"National Allergy Research Centre; Herlev and Gentofte Hospital; University of Copenhagen; DK-2900 Hellerup Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,6,11]]},"reference":[{"key":"10.1111\/bjd.15065-BIB0001|bjd15065-cit-0001","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","article-title":"Atopic dermatitis","volume":"387","author":"Weidinger","year":"2016","journal-title":"Lancet"},{"key":"10.1111\/bjd.15065-BIB0002|bjd15065-cit-0002","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/jdv.13442","article-title":"Qualitative vs. quantitative atopic dermatitis criteria - in historical and present perspectives","volume":"30","author":"Andersen","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.15065-BIB0003|bjd15065-cit-0003","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/jamadermatol.2013.10271","article-title":"Persistence of mild to moderate atopic dermatitis","volume":"150","author":"Margolis","year":"2014","journal-title":"JAMA Dermatology"},{"key":"10.1111\/bjd.15065-BIB0004|bjd15065-cit-0004","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jaci.2014.06.014","article-title":"Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis","volume":"134","author":"Thyssen","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.15065-BIB0005|bjd15065-cit-0005","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaad.2014.03.023","article-title":"Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies","volume":"71","author":"Eichenfield","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.15065-BIB0006|bjd15065-cit-0006","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2340\/00015555-1815","article-title":"Skin barrier integrity and natural moisturising factor levels after cumulative dermal exposure to alkaline agents in atopic dermatitis","volume":"94","author":"Angelova-Fischer","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.15065-BIB0007|bjd15065-cit-0007","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/cod.12139","article-title":"Filaggrin loss-of-function mutations and atopic dermatitis as risk factors for hand eczema in apprentice nurses: part II of a prospective cohort study","volume":"70","author":"Visser","year":"2014","journal-title":"Contact Dermatitis"},{"key":"10.1111\/bjd.15065-BIB0008|bjd15065-cit-0008","first-page":"18","article-title":"Absorption of lidocaine and prilocaine after application of a eutectic mixture of local anesthetics (EMLA) on normal and diseased skin","volume":"69","author":"Juhlin","year":"1989","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.15065-BIB0009|bjd15065-cit-0009","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0923-1811(93)90076-2","article-title":"Skin barrier defect in atopic dermatitis: increased permeability of the stratum corneum using dimethyl sulfoxide and theophylline","volume":"5","author":"Yoshiike","year":"1993","journal-title":"J Dermatol Sci"},{"key":"10.1111\/bjd.15065-BIB0010|bjd15065-cit-0010","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1097\/01.LAB.0000036874.83540.2B","article-title":"Assessment of epidermal barrier function by photoacoustic spectrometry in relation to its importance in the pathogenesis of atopic dermatitis","volume":"82","author":"Hata","year":"2002","journal-title":"Lab Invest"},{"key":"10.1111\/bjd.15065-BIB0011|bjd15065-cit-0011","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2133.2006.07319.x","article-title":"Percutaneous penetration of sodium lauryl sulphate is increased in uninvolved skin of patients with atopic dermatitis compared with control subjects","volume":"155","author":"Jakasa","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15065-BIB0012|bjd15065-cit-0012","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.jid.5700582","article-title":"Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients","volume":"127","author":"Jakasa","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.15065-BIB0013|bjd15065-cit-0013","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/jid.2010.307","article-title":"Skin barrier function in healthy subjects and patients with atopic dermatitis in relation to filaggrin loss-of-function mutations","volume":"131","author":"Jakasa","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.15065-BIB0014|bjd15065-cit-0014","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1365-2133.2009.09036.x","article-title":"Evaluation of out-in skin transparency using a colorimeter and food dye in patients with atopic dermatitis","volume":"160","author":"Mochizuki","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15065-BIB0015|bjd15065-cit-0015","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jaad.2013.08.046","article-title":"Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis: reactivity to topical preservatives","volume":"70","author":"Shaughnessy","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.15065-BIB0016|bjd15065-cit-0016","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaad.2013.12.009","article-title":"Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis: reactivity to surfactants","volume":"70","author":"Shaughnessy","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.15065-BIB0017|bjd15065-cit-0017","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaad.2013.03.012","article-title":"Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis","volume":"69","author":"Malajian","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.15065-BIB0018|bjd15065-cit-0018","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1600-0536.2011.01898.x","article-title":"Prevalence of and factors influencing sensitization to corticosteroids in a Danish patch test population","volume":"64","author":"Vind-Kezunovic","year":"2011","journal-title":"Contact Dermatitis"},{"key":"10.1111\/bjd.15065-BIB0019|bjd15065-cit-0019","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1398-9995.2012.02863.x","article-title":"The association between contact sensitization and atopic disease by linkage of a clinical database and a nationwide patient registry","volume":"67","author":"Thyssen","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/bjd.15065-BIB0020|bjd15065-cit-0020","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/archderm.1989.01670150056006","article-title":"A longitudinal study of contact sensitivity in patients with atopic dermatitis","volume":"125","author":"Uehara","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.15065-BIB0021|bjd15065-cit-0021","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.envres.2014.09.032","article-title":"The effect of phthalate exposure and filaggrin gene variants on atopic dermatitis","volume":"136","author":"Wang","year":"2015","journal-title":"Env Res"},{"issue":"Suppl. 3","key":"10.1111\/bjd.15065-BIB0022|bjd15065-cit-0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408444.2010.515563","article-title":"Personal care products and endocrine disruption: a critical review of the literature","volume":"40","author":"Witorsch","year":"2010","journal-title":"Crit Rev Toxicol"},{"key":"10.1111\/bjd.15065-BIB0023|bjd15065-cit-0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","article-title":"Adverse effects of topical glucocorticosteroids","volume":"54","author":"Hengge","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.15065-BIB0024|bjd15065-cit-0024","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2165\/00002018-200932060-00008","article-title":"Topical corticosteroids and the risk of diabetes mellitus: a nested case-control study in the Netherlands","volume":"32","author":"Linden","year":"2009","journal-title":"Drug Saf"},{"key":"10.1111\/bjd.15065-BIB0025|bjd15065-cit-0025","unstructured":"PubChem http:\/\/pubchem.ncbi.nlm.nih.gov"},{"key":"10.1111\/bjd.15065-BIB0026|bjd15065-cit-0026","unstructured":"United States Environmental Protection Agency Predictive Models and Tools for Assessing Chemicals under the Toxic Substances Control Act (TSCA) http:\/\/www.epa.gov\/oppt\/exposure\/pubs\/episuitedl.htm"},{"key":"10.1111\/bjd.15065-BIB0027|bjd15065-cit-0027","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1016\/j.jaci.2009.07.015","article-title":"Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis","volume":"124","author":"Jensen","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.15065-BIB0028|bjd15065-cit-0028","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2340\/00015555-0562","article-title":"Impact of adult atopic dermatitis on topical drug penetration: assessment by cutaneous microdialysis and tape stripping","volume":"89","author":"Garcia Ortiz","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.15065-BIB0029|bjd15065-cit-0029","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1007\/s11095-011-0515-5","article-title":"Time-correlated single photon counting for simultaneous monitoring of zinc oxide nanoparticles and NAD(P)H in intact and barrier-disrupted volunteer skin","volume":"28","author":"Lin","year":"2011","journal-title":"Pharm Res"},{"key":"10.1111\/bjd.15065-BIB0030|bjd15065-cit-0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.toxlet.2015.03.014","article-title":"Percutaneous penetration of silver from a silver containing garment in healthy volunteers and patients with atopic dermatitis","volume":"235","author":"Pluut","year":"2015","journal-title":"Toxicol Lett"},{"key":"10.1111\/bjd.15065-BIB0031|bjd15065-cit-0031","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/1523-1747.ep12514266","article-title":"Percutaneous absorption of betamethasone 17-benzoate measured by radioimmunoassay","volume":"67","author":"Mizuchi","year":"1976","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.15065-BIB0032|bjd15065-cit-0032","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0190-9622(98)70541-9","article-title":"Tacrolimus (FK506) ointment for atopic dermatitis: a phase I study in adults and children","volume":"38","author":"Alaiti","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.15065-BIB0033|bjd15065-cit-0033","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1046\/j.1365-2133.2001.04133.x","article-title":"First experience of topical SDZ ASM 981 in children with atopic dermatitis","volume":"144","author":"Harper","year":"2001","journal-title":"Br J Dermatol"},{"issue":"Suppl. 1","key":"10.1111\/bjd.15065-BIB0034|bjd15065-cit-0034","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1067\/mjd.2001.109817","article-title":"Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety","volume":"44","author":"Soter","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.15065-BIB0035|bjd15065-cit-0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000051813","article-title":"Low systemic exposure after repeated topical application of Pimecrolimus (Elidel\u00ae, SD Z ASM 981) in patients with atopic dermatitis","volume":"204","author":"Leent","year":"2002","journal-title":"Dermatology"},{"key":"10.1111\/bjd.15065-BIB0036|bjd15065-cit-0036","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/adc.88.11.969","article-title":"Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients","volume":"88","author":"Allen","year":"2003","journal-title":"Arch Dis Child"},{"key":"10.1111\/bjd.15065-BIB0037|bjd15065-cit-0037","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.0022-202X.2005.23644.x","article-title":"A multicenter study of the pharmacokinetics of tacrolimus ointment after first and repeated application to children with atopic dermatitis","volume":"124","author":"Harper","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.15065-BIB0038|bjd15065-cit-0038","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/09546630510033159","article-title":"A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis","volume":"16","author":"Ling","year":"2005","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.15065-BIB0039|bjd15065-cit-0039","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.0022-202X.2005.23754.x","article-title":"Pharmacokinetics of 0.1% tacrolimus ointment after first and repeated application to adults with moderate to severe atopic dermatitis","volume":"125","author":"Rubins","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.15065-BIB0040|bjd15065-cit-0040","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1525-1470.2005.00128.x","article-title":"Low systemic absorption and good tolerability of pimecrolimus, administered as 1% cream (Elidel) in infants with atopic dermatitis - a multicenter, 3-week, open-label study","volume":"22","author":"Staab","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/bjd.15065-BIB0041|bjd15065-cit-0041","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1600-0625.2006.00398.x","article-title":"Low systemic exposure in infants with atopic dermatitis in a 1-year pharmacokinetic study with pimecrolimus cream 1%*","volume":"15","author":"Lakhanpaul","year":"2006","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.15065-BIB0042|bjd15065-cit-0042","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/09546630601121037","article-title":"Blood concentrations of pimecrolimus in adult patients with atopic dermatitis following intermittent administration of pimecrolimus cream 1% (Elidel) for up to 1\u00a0year","volume":"18","author":"Leent","year":"2007","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.15065-BIB0043|bjd15065-cit-0043","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1346-8138.2007.00259.x","article-title":"Blood concentrations, tolerability and efficacy of pimecrolimus cream 1% in Japanese infants and children with atopic dermatitis","volume":"34","author":"Eichenfield","year":"2007","journal-title":"J Dermatol"},{"key":"10.1111\/bjd.15065-BIB0044|bjd15065-cit-0044","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-4632.2009.03853.x","article-title":"The pharmacokinetics of tacrolimus after first and repeated dosing with 0.03% ointment in infants with atopic dermatitis","volume":"48","author":"Reitamo","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.15065-BIB0045|bjd15065-cit-0045","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2133.2008.08974.x","article-title":"Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis","volume":"160","author":"Undre","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15065-BIB0046|bjd15065-cit-0046","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000320125","article-title":"Percutaneous absorption of pimecrolimus is not increased in patients with moderate to severe atopic dermatitis when pimecrolimus cream 1% is applied under occlusion","volume":"221","author":"Thaci","year":"2010","journal-title":"Dermatology"},{"key":"10.1111\/bjd.15065-BIB0047|bjd15065-cit-0047","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2230.1983.tb01758.x","article-title":"Investigation of the pharmacokinetics of clobetasol propionate and clobetasone butyrate after a single application of ointment","volume":"8","author":"Hehir","year":"1983","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.15065-BIB0048|bjd15065-cit-0048","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/09546634.2010.534127","article-title":"The potency of clobetasol propionate: serum levels of clobetasol propionate and adrenal function during therapy with 0.05% clobetasol propionate in patients with severe atopic dermatitis","volume":"23","author":"Velsen","year":"2012","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.15065-BIB0049|bjd15065-cit-0049","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2133.1986.tb06242.x","article-title":"Effect of percutaneous absorption of hydrocortisone on adrenocortical responsiveness in infants with severe skin disease","volume":"115","author":"Turpeinen","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15065-BIB0050|bjd15065-cit-0050","first-page":"331","article-title":"Percutaneous absorption of hydrocortisone during exacerbation and remission of atopic dermatitis in adults","volume":"68","author":"Turpeinen","year":"1988","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.15065-BIB0051|bjd15065-cit-0051","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2133.1988.tb02461.x","article-title":"Influence of age and severity of dermatitis on the percutaneous absorption of hydrocortisone in children","volume":"118","author":"Turpeinen","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15065-BIB0052|bjd15065-cit-0052","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2133.1991.tb00597.x","article-title":"Absorption of hydrocortisone from the skin reservoir in atopic dermatitis","volume":"124","author":"Turpeinen","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15065-BIB0053|bjd15065-cit-0053","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2133.1995.tb02625.x","article-title":"Pharmacokinetics of topical hydrocortisone at plasma level after applications once or twice daily in patients with widespread dermatitis","volume":"133","author":"Aalto-Korte","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15065-BIB0054|bjd15065-cit-0054","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2133.1995.tb02668.x","article-title":"Quantifying systemic absorption of topical hydrocortisone in erythroderma","volume":"133","author":"Aalto-Korte","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15065-BIB0055|bjd15065-cit-0055","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0190-9622(95)90288-0","article-title":"Improvement of skin barrier function during treatment of atopic dermatitis","volume":"33","author":"Aalto-Korte","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.15065-BIB0056|bjd15065-cit-0056","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jaad.2005.06.013","article-title":"Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison","volume":"53","author":"Draelos","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.15065-BIB0057|bjd15065-cit-0057","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1525-1470.1988.tb00904.x","article-title":"Percutaneous absorption of hydrocortisone during and after the acute phase of dermatitis in children","volume":"5","author":"Turpeinen","year":"1988","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/bjd.15065-BIB0058|bjd15065-cit-0058","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jaci.2009.06.046","article-title":"Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens","volume":"124","author":"Scharschmidt","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.15065-BIB0059|bjd15065-cit-0059","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.2353\/ajpath.2010.090957","article-title":"Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermatophagoides pteronyssinus extract","volume":"176","author":"Moniaga","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.15065-BIB0060|bjd15065-cit-0060","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijpharm.2015.12.006","article-title":"What is the discrepancy between drug permeation into\/across intact and diseased skins? Atopic dermatitis as a model","volume":"497","author":"Fang","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1111\/bjd.15065-BIB0061|bjd15065-cit-0061","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/jid.1967.29","article-title":"Regional variation in percutaneous penetration of 14C cortisol in man","volume":"48","author":"Feldmann","year":"1967","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.15065-BIB0062|bjd15065-cit-0062","first-page":"e48","article-title":"Regional variations in percutaneous absorption","volume":"11","author":"Lev-Tov","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.15065-BIB0063|bjd15065-cit-0063","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/pharmaceutics3010053","article-title":"Factors and mechanisms for pharmacokinetic differences between pediatric population and adults","volume":"3","author":"Fernandez","year":"2011","journal-title":"Pharmaceutics"},{"key":"10.1111\/bjd.15065-BIB0064|bjd15065-cit-0064","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/jid.2008.106","article-title":"Animal models of atopic dermatitis","volume":"129","author":"Jin","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.15065-BIB0065|bjd15065-cit-0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.envint.2013.09.002","article-title":"Early life phthalate exposure and atopic disorders in children: a prospective birth cohort study","volume":"62","author":"Wang","year":"2014","journal-title":"Environ Int"},{"key":"10.1111\/bjd.15065-BIB0066|bjd15065-cit-0066","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/bjd.12953","article-title":"Potential nonmonotonous association between di(2-ethylhexyl) phthalate exposure and atopic dermatitis in Korean children","volume":"171","author":"Choi","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15065-BIB0067|bjd15065-cit-0067","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1525-1470.2007.00331.x","article-title":"Cushing syndrome from percutaneous absorption of 1% hydrocortisone ointment in Netherton syndrome","volume":"24","author":"Halverstam","year":"2007","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/bjd.15065-BIB0068|bjd15065-cit-0068","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000358427","article-title":"Adrenal insufficiency as a result of long-term misuse of topical corticosteroids","volume":"228","author":"B\u00f6ckle","year":"2014","journal-title":"Dermatology"},{"key":"10.1111\/bjd.15065-BIB0069|bjd15065-cit-0069","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0190-9622(98)70573-0","article-title":"Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations","volume":"38","author":"Gilbertson","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.15065-BIB0070|bjd15065-cit-0070","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/014107688708000709","article-title":"Adrenal suppression following low-dose topical clobetasol propionate","volume":"80","author":"Ohman","year":"1987","journal-title":"J R Soc Med"},{"issue":"Suppl. 12","key":"10.1111\/bjd.15065-BIB0071|bjd15065-cit-0071","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2133.1976.tb02272.x","article-title":"The effect of percutaneously absorbed steroids on hypothalamic-pituitary-adrenal function after intensive use in in-patients","volume":"94","author":"Munro","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15065-BIB0072|bjd15065-cit-0072","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/archderm.1964.01590290100015","article-title":"Plasma cortisol suppression by steroid creams","volume":"89","author":"Gill","year":"1964","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.15065-BIB0073|bjd15065-cit-0073","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(67)90336-4","article-title":"Pituitary-adrenal function after occlusive topical therapy with betamethasone-17-valerate","volume":"2","author":"James","year":"1967","journal-title":"Lancet"},{"key":"10.1111\/bjd.15065-BIB0074|bjd15065-cit-0074","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1542\/peds.105.4.794","article-title":"Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis","volume":"105","author":"Ellison","year":"2000","journal-title":"Pediatrics"},{"key":"10.1111\/bjd.15065-BIB0075|bjd15065-cit-0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000288163","article-title":"Enhanced absorption through damaged skin: an overview of the in\u00a0vitro human model","volume":"23","author":"Gattu","year":"2010","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1111\/bjd.15065-BIB0076|bjd15065-cit-0076","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000314995","article-title":"Modest but increased penetration through damaged skin: an overview of the in\u00a0vivo human model","volume":"24","author":"Gattu","year":"2010","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1111\/bjd.15065-BIB0077|bjd15065-cit-0077","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0625.2000.009003165.x","article-title":"The 500 Dalton rule for the skin penetration of chemical compounds and drugs","volume":"9","author":"Bos","year":"2000","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.15065-BIB0078|bjd15065-cit-0078","first-page":"747","article-title":"Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome","volume":"137","author":"Allen","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.15065-BIB0079|bjd15065-cit-0079","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-0536.2010.01828.x","article-title":"Preservatives and fragrances in selected consumer-available cosmetics and detergents","volume":"64","author":"Yazar","year":"2011","journal-title":"Contact Dermatitis"},{"key":"10.1111\/bjd.15065-BIB0080|bjd15065-cit-0080","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jaci.2014.07.066","article-title":"Is there a risk using hypoallergenic cosmetic pediatric products in the United States?","volume":"135","author":"Hamann","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.15065-BIB0081|bjd15065-cit-0081","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1398-9995.2008.01890.x","article-title":"Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children","volume":"64","author":"Mailhol","year":"2009","journal-title":"Allergy"},{"key":"10.1111\/bjd.15065-BIB0082|bjd15065-cit-0082","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/all.12358","article-title":"The multiple factors affecting the association between atopic dermatitis and contact sensitization","volume":"69","author":"Thyssen","year":"2014","journal-title":"Allergy"},{"key":"10.1111\/bjd.15065-BIB0083|bjd15065-cit-0083","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/DER.0000000000000084","article-title":"Nickel and cobalt release from children's toys purchased in Denmark and the United States","volume":"25","author":"Jensen","year":"2014","journal-title":"Dermatitis"},{"key":"10.1111\/bjd.15065-BIB0084|bjd15065-cit-0084","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/ACI.0b013e32836457bf","article-title":"The impact of common metal allergens in daily devices","volume":"13","author":"Hamann","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1111\/bjd.15065-BIB0085|bjd15065-cit-0085","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jaci.2012.06.048","article-title":"Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis","volume":"131","author":"Gittler","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.15065-BIB0086|bjd15065-cit-0086","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/pai.12027","article-title":"Positive nickel patch tests in infants are of low clinical relevance and rarely reproducible","volume":"24","author":"Mortz","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1111\/bjd.15065-BIB0087|bjd15065-cit-0087","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archderm.1963.01590150094017","article-title":"Primary irritant patch-test reactions in children","volume":"87","author":"Marcussen","year":"1963","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.15065-BIB0088|bjd15065-cit-0088","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1600-0536.1985.tb01087.x","article-title":"Work-related hand eczema in atopics","volume":"12","author":"Rystedt","year":"1985","journal-title":"Contact Dermatitis"},{"key":"10.1111\/bjd.15065-BIB0089|bjd15065-cit-0089","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ajim.4700080419","article-title":"Hand eczema among hard-metal workers","volume":"8","author":"Fischer","year":"1985","journal-title":"Am J Ind Med"},{"key":"10.1111\/bjd.15065-BIB0090|bjd15065-cit-0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s004200050243","article-title":"Risk for hand eczema in employees with past or present atopic dermatitis","volume":"71","author":"Coenraads","year":"1998","journal-title":"Int Arch Occup Environ Health"},{"key":"10.1111\/bjd.15065-BIB0091|bjd15065-cit-0091","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/bjd.12083","article-title":"Impact of atopic dermatitis and loss-of-function mutations in the filaggrin gene on the development of occupational irritant contact dermatitis","volume":"168","author":"Visser","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15065-BIB0092|bjd15065-cit-0092","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0536.2007.01005.x","article-title":"Occupational autoeczematization or atopic eczema precipitated by occupational contact dermatitis?","volume":"56","author":"Williams","year":"2007","journal-title":"Contact Dermatitis"},{"key":"10.1111\/bjd.15065-BIB0093|bjd15065-cit-0093","unstructured":"World Health Organization International Programme on Chemical Safety. Dermal absorption http:\/\/www.who.int\/ipcs\/features\/2006\/ehc235\/en\/"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.15065","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.15065","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.15065\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:23:43Z","timestamp":1676384623000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/177\/1\/84\/6601899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,11]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.15065","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6,11]]}}}